Advantages of Bloodless Medicine
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/advantages-of-bloodless-medicine/6405/
Patients may choose bloodless medicine for either medical or ethical reasons. How safe and effective are bloodless procedures, compared to more traditional approaches? Dr. Patricia Ford, clinical associate professor of medicine, medical director of the Center for Bloodless Medicine and Surgery and d
Embryo Management and Medical, Ethical Debates
https://reachmd.com/programs/clinicians-roundtable/embryo-management-and-medical-ethical-debates/4306/
The issue of embryo management has come to the forefront recently with the birth of octuplets in California. More than 400 thousand embryos are currently in storage across the United States. Many couples decide to use their embryos at a later date. But what about the embryos that are not used by f
Regeneration: Science Fiction or Reality?
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/regeneration-science-fiction-or-reality/4083/
What are the barriers in science that keep us from reaching the lofty goal of limb and organ regeneration? Host Dr. Leslie Lundt is joined by Dr. Dennis Steindler, the Joseph J. Bagnor/Shands Professor of Medical Research and the executive director of the McKnight Brain Institute at the University o
Advances in ISM Care: Novel Therapies for Reduced Disease Burden
https://reachmd.com/programs/project-oncology/advances-in-ism-care-novel-therapies-for-reduced-disease-burden/26929/
Here’s a look at the latest therapeutic advances for indolent systemic mastocytosis that are helping to reduce the disease and symptom burden.
Reviewing RSV in Immunocompromised Adults
https://reachmd.com/programs/deep-breaths-updates-chest/reviewing-rsv-in-immunocompromised-adults/15336/
How common is RSV in immunocompromised adults? Dive in.
A Deep Dive into the Diagnostic Process for ISM
https://reachmd.com/programs/project-oncology/deep-dive-into-diagnostic-process-for-ISM/26931/
Tune in to hear expert insights on the diagnostic process for indolent systemic mastocytosis (ISM).
Thriving Egg Business: Problems & Solutions
https://reachmd.com/programs/focus-on-cancer/thriving-egg-business-problems-solutions/4164/
Dr. Laurie Zoloth, director of the Northwestern University Center for Bioethics, Science and Society, talks about ovarian cryopreservation, maturation of oocytes in vitro, and politicized laboratory breakthroughs that were intended to meet the needs of female cancer survivors. She argues that we nee
Addressing Tuberculosis and Multi-Drug Resistance at a Cellular Level
https://reachmd.com/programs/clinicians-roundtable/addressing-tuberculosis-and-multi-drug-resistance-at-a-cellular-level/4132/
Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB) has been present in the human population since antiquity. Today over 2 billion people have been exposed. What can we learn form this remarkably resilient bacteria, and how do we address the formidable challenge of treating drug r
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
https://reachmd.com/programs/cme/whim-syndrome-and-cxcr4-variants-new-insights-into-cellular-changes-that-can-impact-patient-treatment-plans/24548/
TBD
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
https://reachmd.com/programs/neurofrontiers/understanding-the-cellular-basis-for-altered-cognition-in-schizophrenia/17873/
What’s the significance of somatostatin messenger RNA levels in the dorsolateral prefrontal cortex in schizophrenia? Tune in to find out.